P

Inventor

BROUGH DOUGLAS E

US57 patents
⚠️ This page may combine multiple inventors who share the name “BROUGH DOUGLAS E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GENVEC INC

45 patents
US6113913ASep 5, 2000

Recombinant adenovirus

GENVEC INC192 citations99
US5965541AOct 12, 1999

Vectors and methods for gene transfer to cells

GENVEC INC163 citations99
US5846782ADec 8, 1998

Targeting adenovirus with use of constrained peptide motifs

GENVEC INC336 citations99
US5731190AMar 24, 1998

Penton base protein and methods of using same

GENVEC INC123 citations99
US5712136AJan 27, 1998

Adenoviral-mediated cell targeting commanded by the adenovirus penton base protein

GENVEC INC140 citations99
US5994106ANov 30, 1999

Stocks of recombinant, replication-deficient adenovirus free of replication-competent adenovirus

GENVEC INC405 citations98
US5851806ADec 22, 1998

Complementary adenoviral systems and cell lines

GENVEC INC290 citations98
US7195896B2Mar 27, 2007

Complementary adenoviral vector systems and cell lines

GENVEC INC74 citations97
US6482616B1Nov 19, 2002

RCA-free adenoviral vector system and propagation method

GENVEC INC97 citations97
US5559099ASep 24, 1996

Penton base protein and methods of using same

GENVEC INC269 citations97
US6677156B2Jan 13, 2004

Non-adenoviral gene product-based complementing cells for adenoviral vectors

GENVEC INC46 citations96
US6660521B2Dec 9, 2003

Use of trans-activation and CIS-activation to increase the persistence of a transgene in an at least E4-deficient adenovirus

GENVEC INC73 citations96
US6465253B1Oct 15, 2002

Vectors and methods for gene transfer to cells

GENVEC INC53 citations96
US6951755B2Oct 4, 2005

Vectors and methods for gene transfer

GENVEC INC20 citations93
US6649373B2Nov 18, 2003

Use of trans-activation and CIS-activation to modulate the persistence of expression of a transgene

GENVEC INC16 citations93
US6225113B1May 1, 2001

Use of trans-activation and cis-activation to modulate the persistence of expression of a transgene in an at least E4-deficient adenovirus

GENVEC INC33 citations93
US6821775B1Nov 23, 2004

Viral vector encoding pigment epithelium-derived factor

GENVEC INC24 citations92
US6682929B2Jan 27, 2004

Adenovector complementing cells

GENVEC INC45 citations92
US6475757B2Nov 5, 2002

Plasmids for construction of eukaryotic viral vectors

GENVEC INC23 citations92
US6329200B1Dec 11, 2001

Plasmids for construction of eukaryotic viral vectors

GENVEC INC29 citations92
US6440728B1Aug 27, 2002

Chimeric vectors comprising a phage packaging site and a portion derived from the genome of a eukaryotic virus

GENVEC INC23 citations90
US10272162B2Apr 30, 2019

Affenadenovirus (gorilla) or adenoviral vectors and methods of use

GENVEC INC8 citations84
US10059962B2Aug 28, 2018

Simian (gorilla) adenovirus or adenoviral vectors and methods of use

GENVEC INC5 citations84
US9617560B2Apr 11, 2017

Simian (gorilla) adenovirus or adenoviral vectors and methods of use

GENVEC INC7 citations84
US9790519B2Oct 17, 2017

Modified serotype 28 adenoviral vectors

GENVEC INC8 citations82
US6913927B2Jul 5, 2005

Non-adenoviral gene product-based complementing cells for adenoviral vectors

GENVEC INC5 citations74
US9580476B2Feb 28, 2017

Adenoviral vector-based respiratory syncytial virus (RSV) vaccine

GENVEC INC3 citations73
US9388429B2Jul 12, 2016

Method for propagating adenoviral vectors encoding inhibitory gene products

GENVEC INC3 citations73
US6579522B1Jun 17, 2003

Replication deficient adenoviral TNF vector

GENVEC INC11 citations70
US9676824B2Jun 13, 2017

Herpes simplex virus vaccine

GENVEC INC4 citations68
US6998263B2Feb 14, 2006

Methods of preparing and using a viral vector library

GENVEC INC3 citations63
US11359214B2Jun 14, 2022

Simian (gorilla) adenovirus or adenoviral vectors and methods of use

GENVEC INC0 citations62
US11034975B2Jun 15, 2021

Affenadenovirus (gorilla) or adenoviral vectors and methods of use

GENVEC INC0 citations62
US9629906B2Apr 25, 2017

Affenadenovirus (gorilla) or adenoviral vectors and methods of use

GENVEC INC1 citations62
US9233153B2Jan 12, 2016

Affenadenovirus (gorilla) or adenoviral vectors and methods of use

GENVEC INC1 citations62
US10947560B2Mar 16, 2021

Modified serotype 28 adenoviral vectors

GENVEC INC0 citations61
US7070930B2Jul 4, 2006

Chimeric vectors comprising a phage packaging site and a portion derived from the genome of a eukaryotic virus

GENVEC INC2 citations60
US11279951B2Mar 22, 2022

Adenoviral vector encoding human atonal homolog-1 (HATH1)

GENVEC INC0 citations58
US11155832B2Oct 26, 2021

Adenovectors for delivery of therapeutic genetic material into T cells

GENVEC INC0 citations53
US10792376B2Oct 6, 2020

Affenadenovirus (gorilla) or adenoviral vectors and methods of use

GENVEC INC0 citations52
US10787682B2Sep 29, 2020

Simian (gorilla) adenovirus or adenoviral vectors and methods of use

GENVEC INC0 citations52
US10640776B2May 5, 2020

Method for propagating adenoviral vectors encoding inhibitory gene products

GENVEC INC0 citations52
US10260074B2Apr 16, 2019

Affenadenovirus (gorilla) or adenoviral vectors and methods of use

GENVEC INC0 citations52
US9725738B2Aug 8, 2017

Affenadenovirus (gorilla) or adenoviral vectors and methods of use

GENVEC INC0 citations52
US6458578B1Oct 1, 2002

Recombinant cell line produces adenoviral gene products E1 and DEF-A, and/or DEF-B

GENVEC INC0 citations52

PRECIGEN INC

3 patents

BRUDER JOSEPH T

1 patent

BROUGH DOUGLAS E

1 patent

Showing the top 50 of 57 patents by PatentIndex Score.